Delivery Order SPE2DR25D2009-SPE2DR26FJ2U6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Dupixent 300 mg/2 mL pen injectors with a ceiling value of $9,330.60 under a firm fixed-price contract type. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, with performance to take place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order utilizes no set-aside designation and was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $14,595.53 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on October 30, 2025, with an ultimate completion date of October 31, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors with a ceiling value of $10,904.76 under a firm fixed-price contract type. The award was made on October 27, 2025, with an ultimate completion date of October 28, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $12,806.82 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on August 26, 2025. This firm fixed price, non-competitive delivery order will be fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. The award represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply portfolio serving...
- The Defense Logistics Agency awarded a delivery order valued at $13,526.92 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on November 3, 2025, with an ultimate completion date of November 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract for pharmaceutical supply. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, which serves as the company's...
- The Defense Logistics Agency awarded a delivery order valued at $36,944.08 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed price, competitively awarded delivery order represents a direct fulfillment under the company's existing pharmaceutical supply agreement with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors, with a contract ceiling value of $25,198.23. The award, issued on October 23, 2025, with an ultimate completion date of October 24, 2025, utilizes firm fixed-price pricing under a competitive, non-set-aside arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors, with a contract ceiling value of $44,612.34. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $9,101.94 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors with a contract ceiling value of $12,961.53 under a firm fixed price arrangement. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive, direct delivery against the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ2U6Delivery Order
The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors with a ceiling value of $98,228.54. This firm fixed-price delivery order, issued on November 3, 2025, is scheduled for completion by November 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, demonstrating the contractor's capability to compete in open federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor and critical vendor to federal healthcare systems, AmerisourceBergen Drug Corp supplies a broad range of medications and medical products to support military healthcare programs, including specialty drugs, vaccines, and medical devices across multiple therapeutic domains. The contract supports customers including the Defense Health Agency and U.S. Coast Guard through this flexible procurement vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $98.2k | 11/3/25 |